--- title: "Weekly Recap | Esab -8.13%, consensus target above spot" type: "News" locale: "en" url: "https://longbridge.com/en/news/299510837.md" description: "Esab fell 8.13% this week to close at $64.94, trailing the S&P 500 by about 8.05 percentage points. The move was a fade from an early high: shares opened Monday at $68.44, tagged the week’s high of $70.00, then slid through the week. Friday (Sept 18) marked the low of $64.83, which is also the bottom of the 60-day range, and the stock settled just above that at $64.94. Selling pressure picked up into the second half, with only Thursday managing a brief rebound." datetime: "2026-09-19T05:59:35.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/299510837.md) - [en](https://longbridge.com/en/news/299510837.md) - [zh-HK](https://longbridge.com/zh-HK/news/299510837.md) generator: "portal-rs" --- # Weekly Recap | Esab -8.13%, consensus target above spot ## The Week Esab fell 8.13% this week to close at $64.94, trailing the S&P 500 by about 8.05 percentage points. The move was a fade from an early high: shares opened Monday at $68.44, tagged the week’s high of $70.00, then slid through the week. Friday (Sept 18) marked the low of $64.83, which is also the bottom of the 60-day range, and the stock settled just above that at $64.94. Selling pressure picked up into the second half, with only Thursday managing a brief rebound. ## Key Events The week’s news centred on restructuring and capital spending among mid-cap industrial machinery names. On Wednesday, Sept 16, three related headlines appeared: a cross-sector shake-up covering nine mid-cap stocks pushing 2026 overhauls, capital expenditure signals from industrial and hardware equipment makers leaning toward M&A and capacity deployment, and defence contract wins plus clinical funding driving niche industrial and medical expansion. Esab’s industrial machinery segment was flagged among the areas showing capital-spending momentum. Over the weekend, a momentum screen on Sept 19 listed Esab among the 10 weakest mid-cap industrial stocks, matching the price action this week. ## Analyst Ratings Coverage totals 11 firms: 9 rate it buy, 1 over, and 1 hold, with no under or sell. The consensus rating is strong buy, with a consensus target of $128.73, roughly 98.22% above the current $64.94. Target prices range from $100 to $145, so the spread is wide. Within industrial machinery, Esab ranks 18th out of 85 covered names. ## The Week Ahead The macro calendar picks up from Tuesday to Thursday. The Richmond Fed composite index lands on Tuesday, Sept 22, versus a prior reading of 4. Wednesday, Sept 23 brings the EIA weekly crude inventory and Cushing crude inventory, with prior prints of -0.64 and -0.342. Thursday, Sept 24 delivers initial jobless claims (prior 196), the current account balance (prior -226.8), new home sales at an estimated 0.608, and the EIA natural gas storage change (prior 44). Industrial names tend to be sensitive to manufacturing gauges, so the Richmond index and new home sales are worth watching for any turn in sector sentiment. ## In Short This week sets up a clear tension between price weakness and a positive analyst skew. The stock dropped 8.13% and marked a 60-day low, yet 10 of 11 brokers rate it buy or over, and the consensus target sits nearly double the spot price. On valuation, the stock trades around 23.57 times earnings and 1.71 times book, on the lower side of its recent range. The latest session’s fund flow showed small and medium orders net buying while large orders were net sellers, so the tape is split. What matters next is whether the industrial capex theme can draw buyers back, and whether next week’s manufacturing-related macro data stabilises sector tone. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [ESAB.US](https://longbridge.com/en/quote/ESAB.US.md) ## Related News & Research - [ESAB Corp beats Q2 sales estimates, raises FY core net sales growth](https://longbridge.com/en/news/295093523.md) - [ESAB Corporation (NYSE:ESAB) Given Consensus Recommendation of "Moderate Buy" by Brokerages](https://longbridge.com/en/news/295634233.md) - [Coca-Cola Hasn't Sold Much More Soda in a Decade. Its Dividend Has Gone Up Every Year Anyway.](https://longbridge.com/en/news/300177696.md) - [Alphabet vs. Tesla: One Mag 7 Stock Is a Winner, the Other Faces Too Many Questions](https://longbridge.com/en/news/300143230.md) - [BUZZ-ADARx Pharmaceuticals set to open higher in Nasdaq debut after upsized $446.3 million IPO](https://longbridge.com/en/news/300145098.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**